Green bamboo biological sprint Hong Kong stocks: loss of more than 500million during the year, tiger medicine and Beijing Yizhuang are shareholders

RedI network Lei Jianping 7 month 1 Reported Wednesday

Beijing green bamboo Biotechnology Co., Ltd （ abbreviation ：“ Green bamboo creatures ”） The prospectus was submitted a few days ago , Ready to list in Hong Kong .

Loss during the year 5.39 Billion

Green bamboo biology was founded in 2001 year 11 month , Located in Guangtong street, Tongzhou Industrial Development Zone, Beijing 3 Number , Covers an area of 27 mu . Green bamboo biology is a biotechnology company committed to providing high-quality and affordable human vaccines and therapeutic biological agents , To prevent and control infectious diseases and solve the main unmet medical needs in the treatment of cancer and autoimmune diseases .

Green bamboo biology has developed 3 A polysaccharide protein conjugate vaccine 、2 Polysaccharide vaccine and 1 A virus inactivated vaccine , this 6 All vaccine products were transferred to Beijing Zhifei Lvzhu biopharmaceutical Co., Ltd .

Company self 2009 In, human monoclonal antibody 、 Bispecific antibody drugs 、 Research on recombinant virus vaccine ,2017 Obtained the clinical approval of monoclonal antibody biological analogues 2 individual ,2019 Get treatment in B Bispecific antibodies for cell leukemia and lymphoma K193 Clinical approval of antibody injection 1 individual ,2021 year 8 The recombinant herpes zoster vaccine was approved to enter the clinical research .

The prospectus shows , Green bamboo creatures 2020 year 、2021 The annual revenue is 498 Ten thousand yuan 、 690 Ten thousand yuan ; The losses during the period were 1.74 One hundred million yuan 、5.39 One hundred million yuan .

Green bamboo creatures 2022 The first quarter of the year's revenue was 358 Ten thousand yuan , The revenue in the same period last year was 112 Ten thousand yuan ; The loss during the period is 4430 Ten thousand yuan , The loss in the previous year was 1.19 One hundred million yuan .

By 2022 year 3 month 31 Japan , The cash equivalents of cash set held by green bamboo biology are 1742 Ten thousand yuan .

Tiger medicine and Beijing Yizhuang are shareholders

The executive directors of green bamboo biology are Kong Jian 、 Ms. Zhang Yanping 、 Ms. Jiang Xianmin ; The non-executive directors are ma Xiang 、 Kong Shuangquan ; The independent non-executive directors are Liang Weiye 、 Liang Yeya 、 Ms. Hou Aijun .

2021 year 8 month 30 Japan , Green bamboo biology announced the completion 3.5 Billions of B Round of funding , Led by CCB International , Two families A+H Listed company tiger pharmaceutical 、 Jinjiang zhenrui 、 Zhuhai Lizhu 、 Hangzhou Taikun 、 Henderson Rongyu 、 Follow up investment of Xinchuang Technology .

Green bamboo creatures B After the rotation, the valuation is 21.5 One hundred million yuan , The price per share is 12.86 element .

2021 year 12 End of month , The green bamboo creature completes 1.2 One hundred million yuan B+ Round of funding , Investors include Hainan Zhaoan 、 Gongqing city is becoming sharper 、 Jinjiang Xuanhong 、 Shaanxi jin'ou and Hengji Rongyu . Green bamboo creatures B+ After the rotation, the valuation is 31.3 One hundred million yuan , The price per share is 17.98 element .

2022 year 6 month 27 Japan , The green bamboo creature completes C round 2.18 One hundred million yuan financing , Investors include Huapu Haihe biomedical Fund , Yizhuang biomedical fund and Xinyin Zhenhua . Green bamboo creatures C After the rotation, the valuation is 44.2 One hundred million yuan , The price per share is 23 element .

IPO front , Kong Jian holds 30.35%, Ms. Zhang Yanping holds 10.52%, Hengqin Lvzhu limited partnership holds 6.41%,

Kong Jian and Ms. Zhang Yanping are husband and wife , Totally control the company 47.28% Equity of . Kong Jian is the general manager of the company 、 Chairman of the board ; Ms. Zhang Yanping is the deputy general manager .

Beijing Yizhuang holds 10.23%, Beijing Yizhuang phase II holds 9.54%;

Beijing saisheng holds 7.16%, CCB capital holds 6.07%, Jinjiang zhenrui holds 4.05%, Henderson Rongyu holds 2.76%;

Ms. Jiang Xianmin holds shares 2.08%, Deputy general manager and vice chairman of the board ; Tianjin Huapu holds 1.58%; Ms. Zhong Siyu holds shares 1.23%, Zhuhai Lizhu 、 Hangzhou Taikun holds shares respectively 1.21%.

———————————————

Lei Di was founded by Lei Jianping, a senior media person , If reproduced, please indicate the source .